Hypothalamic hamartomas: optimal approach to clinical evaluation and diagnosis

Area of Science:

• Neurosurgery
• Neurology
• Medical Technology

Background:

• Hypothalamic hamartomas (HHs) cause medically intractable gelastic seizures.
• Conventional surgical treatments for HHs have limited efficacy and potential for significant morbidity.

Purpose of the Study:

• To evaluate the safety and efficacy of magnetic resonance imaging (MRI)-guided stereotactic laser ablation (SLA) for treating epileptogenic hypothalamic hamartomas.

Main Methods:

• Fourteen patients with refractory gelastic epilepsy underwent MRI-guided SLA using a novel laser system.
• A minimally invasive approach involved a 3.2-mm twist drill hole for catheter insertion and real-time MRI thermometry for ablation.

Main Results:

• Seizure freedom was achieved in 12 out of 14 patients (86%) with a mean follow-up of 9 months.
• No permanent surgical complications, neurological deficits, or neuroendocrine disturbances were observed.
• One patient experienced a minor, asymptomatic subarachnoid hemorrhage; most patients were discharged within 24 hours.

Conclusions:

• Stereotactic laser ablation (SLA) is a safe, effective, and minimally invasive option for ablating hypothalamic hamartomas (HHs).
• This technique shows promise for improving outcomes in patients with medically refractory gelastic epilepsy due to HHs.